These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 7479444)

  • 1. [Regulation of the cell cycle--involvement of protein inhibitors of cyclin-dependent kinases].
    Grzelakowska-Sztabert B
    Postepy Biochem; 1995; 41(2):80-93. PubMed ID: 7479444
    [No Abstract]   [Full Text] [Related]  

  • 2. Lovastatin induction of cyclin-dependent kinase inhibitors in human breast cells occurs in a cell cycle-independent fashion.
    Gray-Bablin J; Rao S; Keyomarsi K
    Cancer Res; 1997 Feb; 57(4):604-9. PubMed ID: 9044834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p18(INK4c) collaborates with other CDK-inhibitory proteins in the regenerating liver.
    Luedde T; Rodriguez ME; Tacke F; Xiong Y; Brenner DA; Trautwein C
    Hepatology; 2003 Apr; 37(4):833-41. PubMed ID: 12668976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity.
    Schreiber M; Muller WJ; Singh G; Graham FL
    Oncogene; 1999 Mar; 18(9):1663-76. PubMed ID: 10208428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
    Korkolopoulou P; Christodoulou P; Konstantinidou AE; Thomas-Tsagli E; Kapralos P; Davaris P
    Hum Pathol; 2000 Jun; 31(6):751-60. PubMed ID: 10872671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cyclin-dependent kinase inhibitors in mammal cells].
    Jiang H; Wang YC
    Sheng Li Ke Xue Jin Zhan; 1996 Apr; 27(2):107-12. PubMed ID: 9592231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of expression and activity of distinct pRB, E2F, D-type cyclin, and CKI family members during terminal differentiation of P19 cells.
    Gill RM; Slack R; Kiess M; Hamel PA
    Exp Cell Res; 1998 Oct; 244(1):157-70. PubMed ID: 9770359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Under arrest at atomic resolution.
    Morgan DO
    Nature; 1996 Jul; 382(6589):295-6. PubMed ID: 8684452
    [No Abstract]   [Full Text] [Related]  

  • 9. Herpes simplex virus type 1 infection imposes a G(1)/S block in asynchronously growing cells and prevents G(1) entry in quiescent cells.
    Ehmann GL; McLean TI; Bachenheimer SL
    Virology; 2000 Feb; 267(2):335-49. PubMed ID: 10662629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p27: a pleiotropic regulator of cellular phenotype and a target for cell cycle dysregulation in cancer.
    Desdouets C; Bréchot C
    Pathol Biol (Paris); 2000 Apr; 48(3):203-10. PubMed ID: 10858954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases.
    Touyz RM; Yao G
    J Cell Physiol; 2003 Dec; 197(3):326-35. PubMed ID: 14566962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of cyclin E and cyclin-dependent kinase inhibitor (p27Kip1): effect on cell cycle regulation in HeLa cells.
    Kwon TK; Nordin AA
    Biochem Biophys Res Commun; 1997 Sep; 238(2):534-8. PubMed ID: 9299546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased p27Kip1 cyclin-dependent kinase inhibitor gene expression following anti-IgM treatment promotes apoptosis of WEHI 231 B cells.
    Wu M; Bellas RE; Shen J; Yang W; Sonenshein GE
    J Immunol; 1999 Dec; 163(12):6530-5. PubMed ID: 10586045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of G1 cyclins, cyclin-dependent kinases, and cyclin-dependent kinase inhibitors in androgen-induced prostate proliferation in castrated rats.
    Chen Y; Robles AI; Martinez LA; Liu F; Gimenez-Conti IB; Conti CJ
    Cell Growth Differ; 1996 Nov; 7(11):1571-8. PubMed ID: 8930407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the v-Src oncoprotein in fibroblasts disrupts normal regulation of the CDK inhibitor p27 and inhibits quiescence.
    Johnson D; Frame MC; Wyke JA
    Oncogene; 1998 Apr; 16(15):2017-28. PubMed ID: 9591786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of cyclin-dependent kinases and their inhibitors in cellular differentiation and development.
    Chellappan SP; Giordano A; Fisher PB
    Curr Top Microbiol Immunol; 1998; 227():57-103. PubMed ID: 9479826
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibitors of mammalian G1 cyclin-dependent kinases.
    Sherr CJ; Roberts JM
    Genes Dev; 1995 May; 9(10):1149-63. PubMed ID: 7758941
    [No Abstract]   [Full Text] [Related]  

  • 18. Inactivation of cyclin-dependent kinase inhibitor genes and development of human acute leukemias.
    Ragione FD; Iolascon A
    Leuk Lymphoma; 1997 Mar; 25(1-2):23-35. PubMed ID: 9130611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of cyclin-dependent kinase inhibitors: lessons from knockout mice.
    Kiyokawa H; Koff A
    Curr Top Microbiol Immunol; 1998; 227():105-20. PubMed ID: 9479827
    [No Abstract]   [Full Text] [Related]  

  • 20. Overcoming inhibitions: subversion of CKI function by viral cyclins.
    Swanton C; Card GL; Mann D; McDonald N; Jones N
    Trends Biochem Sci; 1999 Mar; 24(3):116-20. PubMed ID: 10203759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.